POST Online Media Lite Edition


Centogene appoints Sun Kim as interim chief business officer

Christian Fernsby |
Berlin, Germany - Centogene, a biotechnology company, announced that Sun Kim, current chief strategy and IR officer, will be interim chief business officer.

Article continues below

Prior to joining Centogene, Mr. Kim was Head of Corporate Strategy at Shire Plc.

Prior to joining Shire Plc, he worked in the Alcon division of Novartis in multiple roles, including General Manager of Singapore and Global Head of Strategy.

Mr. Kim also worked at Bausch and Lomb, leading its strategy function for the pharmaceutical business unit and the global generics franchise.


Castolin Eutectic names Patrick Fetzer as global CEO
Piëch Automotive appoints leading auto executives
Commerzbank appoints Manfred Kno as chairman
Coca-Cola Germany appoints Bjorn Jensen as managing director
Donatus Kaufmann to leave executive board of Thyssenkrupp